News - Forteo


Current filters:


Popular Filters

Eli Lilly exceeds expectations with third quarter results

Eli Lilly exceeds expectations with third quarter results


US pharma major Eli Lilly has announced financial results for the third quarter of 2013. Despite the…

AlimtaAmyvidAxironCialisCymbaltaEffientEli LillyEvistaFinancialForteoHumalogNorth AmericaPharmaceuticalStratteraTrajentaZyprexa

Eli Lilly records higher than expected earnings in 2nd-qtr results


US drug major Eli Lilly's (NYSE: LLY) recorded higher than expected earnings as growth in key products…

AlimtaCialisCymbaltaEffientEli LillyEvistaFinancialForteoHumalogNorth AmericaPharmaceuticalStratteraZyprexa

Critical Pharma links with academia on osteoporosis nasal spray


Critical Pharmaceuticals, an emerging UK biotechnology company, and The University of Nottingham, UK,…

Anti-Arthritics/RheumaticsBiotechnologyCritical PharmaceuticalsForteoResearchteriparatide

URMC research shows Lilly’s Forteo could extend life of arthritic joints


A drug already approved to build bone mass in patients with osteoporosis also builds cartilage around…

Anti-Arthritics/RheumaticsEli LillyForteoPharmaceuticalResearch

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top